Stamford, CT -- (SBWIRE) -- 12/03/2013 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), NanoTech Entertainment, Inc. (OTCMKTS:NTEK), Keryx Biopharmaceuticals (NASDAQ:KERX), General Motors Company (NYSE:GM).
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) opened its last trade at the price of $1.12. Its closing price was $1.11 after losing -3.48% for the day. The company traded with the total volume of 2.48 million shares, while its average trading volume remained 1.69 million shares. The beta of this stock stands at 1.26. Aeterna Zentaris Inc., a specialty biopharmaceutical company, is engaged in developing and commercializing treatments in oncology and endocrinology worldwide. It markets Cetrotide, a luteinizing hormone-releasing hormone antagonist treatment for in vitro fertilization.
Has AEZS Found The Bottom and Ready To Move Up? Find Out Here
NanoTech Entertainment, Inc. (OTCMKTS:NTEK) percentage change plunged -9.30% to close at $0.156 with the total traded volume of 5.01 million shares, along with average volume of 6.13 million shares. The 52 week range of the stock remained $0.00 - $0.18, while its day lowest price was $0.15. The share price hit the day highest price of $0.17. NanoTech Entertainment, Inc. operates as a technology company with focus on entertainment industry worldwide. The company virtual manufactures and develops technology and games, and then licenses to coin-op arcade, casino gaming, and consumer gaming markets.
Has NTEK Found The Bottom And Ready To Gain Momentum? Find Out Here
Keryx Biopharmaceuticals (NASDAQ:KERX) traded on volume of 5.52 million shares in the last session against average volume of 3.08 million shares. The company started its trading session with the price of $13.99 and closed at $14.59 by scoring +5.04%. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Will KERX Continue To Move Higher? Find Out Here
General Motors Company (NYSE:GM) started its last trading session with the price of $39.10 and closed at $39.11 by scoring +0.98%. The stock traded with total volume of 21.20 million shares, while the average trading volume remained 21.18 million shares. Day range for the stock was $38.91 - $39.39. General Motors Company (GM) designs, manufactures, and markets cars, crossovers, trucks, and automobile parts worldwide. The company markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Opel, Holden, and Vauxhall brand names, as well as under the Alpheon, Jiefang, Baojun, and Wuling brand names.
Why Should Investors Buy GM After The Recent Gain? Just Go Here and Find Out
About Wall Street Pennies
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “http://www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by http://www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)